The prospective multi-centre BIO-LivIQ trial will enrol 325 patients across 60 sites worldwide.

The placement device for the LivIQ leadless pacemaker. [Image courtesy of Biotronik] Biotronik today announced the initiation ...

International BIO-LivIQ Study Will Generate Evidence for Global LivIQ Leadless Pacemaker Approvals; Far-Field Sensing and ...

PHILADELPHIA — Accelerometer-based atrial sensing with a novel, enhanced, automated algorithm in patients with atrioventricular block and a single-chamber leadless pacemaker in the right ventricle ...

Aims: Third-generation mobile phones, UMTS (Universal Mobile Telecommunication System), were recently introduced in Europe. The safety of these devices with regard to their interference with implanted ...

Last May, a widely reported study concluded that errant electronic noise from iPods can cause implantable cardiac pacemakers to malfunction. This just didn’t sound right to the cardiac ...

Last summer, Northwestern University researchers introduced the first-ever transient pacemaker — a fully implantable, wireless device that harmlessly dissolves in the body after it’s no longer needed.

Texas Heart Institute (THI) was awarded a prestigious four-year, $2.39 million grant from the National Institutes of Health (NIH) to explore further the development of a novel pacemaker system that is ...